JPS5692219A - Purification of biologically original particle* particularly antigen *aghbs* of b type hepatitis virus surface - Google Patents

Purification of biologically original particle* particularly antigen *aghbs* of b type hepatitis virus surface

Info

Publication number
JPS5692219A
JPS5692219A JP17192480A JP17192480A JPS5692219A JP S5692219 A JPS5692219 A JP S5692219A JP 17192480 A JP17192480 A JP 17192480A JP 17192480 A JP17192480 A JP 17192480A JP S5692219 A JPS5692219 A JP S5692219A
Authority
JP
Japan
Prior art keywords
aghbs
biologically
purification
hepatitis virus
virus surface
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP17192480A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0133157B2 (cg-RX-API-DMAC10.html
Inventor
Adamobuitsu Fuiritsupu
Purateru Aruberuto
Miyuraa Ruutobuihi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Publication of JPS5692219A publication Critical patent/JPS5692219A/ja
Publication of JPH0133157B2 publication Critical patent/JPH0133157B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Centrifugal Separators (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP17192480A 1979-12-07 1980-12-05 Purification of biologically original particle* particularly antigen *aghbs* of b type hepatitis virus surface Granted JPS5692219A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7930135A FR2470795A1 (fr) 1979-12-07 1979-12-07 Procede de purification de particules d'origine biologique, notamment de l'antigene de surface du virus de l'hepatite b (aghbs) et les produits obtenus

Publications (2)

Publication Number Publication Date
JPS5692219A true JPS5692219A (en) 1981-07-25
JPH0133157B2 JPH0133157B2 (cg-RX-API-DMAC10.html) 1989-07-12

Family

ID=9232533

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17192480A Granted JPS5692219A (en) 1979-12-07 1980-12-05 Purification of biologically original particle* particularly antigen *aghbs* of b type hepatitis virus surface

Country Status (5)

Country Link
US (1) US4335214A (cg-RX-API-DMAC10.html)
JP (1) JPS5692219A (cg-RX-API-DMAC10.html)
DE (1) DE3045990C2 (cg-RX-API-DMAC10.html)
FR (1) FR2470795A1 (cg-RX-API-DMAC10.html)
GB (1) GB2064322B (cg-RX-API-DMAC10.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59101426A (ja) * 1982-11-29 1984-06-12 Green Cross Corp:The Ｂ型肝炎感染予防用ワクチンの製造方法
FR2561256B1 (fr) * 1984-03-16 1987-01-02 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite
US4683294A (en) * 1985-04-03 1987-07-28 Smith Kline Rit, S.A. Process for the extraction and purification of proteins from culture media producing them
FR2632308B1 (fr) * 1988-06-07 1991-08-16 Fondation Nale Transfusion San Procede et installation de fractionnement en continu de proteines vegetales animales ou humaines
US5462863A (en) * 1989-02-09 1995-10-31 Development Center For Biotechnology Isolation of Hepatitis B surface antigen from transformed yeast cells
CN113583801A (zh) * 2020-04-30 2021-11-02 上海青赛生物科技有限公司 一种病毒密度梯度离心纯化装置

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139619A (en) * 1975-05-14 1976-12-02 Merck & Co Inc Hepatisis b vaccine
JPS54101421A (en) * 1978-01-27 1979-08-10 Merck & Co Inc Hepatitis b surface antigen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2150559A1 (en) * 1971-06-09 1973-04-13 Merieux Inst Australia antigen purification - for preparation of purified suspensions
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
GB1486557A (en) * 1973-10-18 1977-09-21 Flockhart & Co Process for the preparation of pyrogen-free sub-unit vaccine
US3951937A (en) * 1973-12-20 1976-04-20 The Community Blood Council Of Greater New York, Inc. Large scale purification of hepatitis type B antigen using polyethylene glycol
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
FR2338051A1 (fr) * 1976-01-19 1977-08-12 Community Blood Council Greate Procede de preparation d'antigene d'hepatite b purifie et produits obtenus
US4088748A (en) * 1976-11-02 1978-05-09 Merck & Co., Inc. Hepatitis B surface antigen
US4118477A (en) * 1977-02-14 1978-10-03 Merck & Co., Inc. Hepatitis B antigen
GB1554812A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
FR2412315A1 (fr) * 1977-02-23 1979-07-20 Merck & Co Inc Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
US4102996A (en) * 1977-04-20 1978-07-25 Merck & Co., Inc. Method of preparing hepatitis B core antigen
FR2415639A1 (fr) * 1978-01-27 1979-08-24 Merck & Co Inc Antigene de surface de l'hepatite b
DE2803920A1 (de) * 1978-01-30 1979-08-02 Merck & Co Inc Verfahren zur gewinnung von hepatitis b-oberflaechenantigen
DK187679A (da) * 1978-05-08 1979-11-09 Merck & Co Inc Fremgangsmaade til direkte ekstraktion af smaa partikler fra en proteinholdig vaeske
US4217418A (en) * 1978-05-08 1980-08-12 Merck & Co., Inc. Recovery of small particles by flow centrifugation
US4204989A (en) * 1978-12-13 1980-05-27 Merck & Co., Inc. Isolation of hepatitis B e antigen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139619A (en) * 1975-05-14 1976-12-02 Merck & Co Inc Hepatisis b vaccine
JPS54101421A (en) * 1978-01-27 1979-08-10 Merck & Co Inc Hepatitis b surface antigen

Also Published As

Publication number Publication date
JPH0133157B2 (cg-RX-API-DMAC10.html) 1989-07-12
FR2470795A1 (fr) 1981-06-12
US4335214A (en) 1982-06-15
GB2064322A (en) 1981-06-17
DE3045990A1 (de) 1981-09-03
DE3045990C2 (de) 1985-08-22
FR2470795B1 (cg-RX-API-DMAC10.html) 1983-07-01
GB2064322B (en) 1983-11-09

Similar Documents

Publication Publication Date Title
PT86640A (pt) Hepatitis b virus surface antigens and hybrid antigens containing them
GB2070621B (en) Nucleotidic sequence coding the surface antigen of the hepatitis b virus vector containing said nucleotidic sequence process allowing the obtention thereof and antigen obtained thereby
GB2212511B (en) Hepatitis c virus
GB2099804B (en) Sintering of particulate material
GB2051357B (en) Simultaneous detection of sindicators of hepatitis virus exposure
AU8746582A (en) Hepatitis b virus e type antigen
EP0232921A3 (en) Monoclonal antibodies against hepatitis b virus
DE3474775D1 (en) Method for purification of hepatitis b virus surface antigen
GB2108527B (en) Non-a non-b hepatitis virus
DE3378959D1 (en) Methods for preparation of hepatitis b surface antigen free gamma globulins and products
PT85137A (en) T and b cell epitopes of the pre-s region of hepatitis b virus surface antigen
HRP921353A2 (en) Biomass for the production of viruses/virus antigenes
NZ203190A (en) Vaccines of infections bronchitis virus
JPS5692219A (en) Purification of biologically original particle* particularly antigen *aghbs* of b type hepatitis virus surface
HU9303066D0 (en) Particle forming multiply hepatitis b virus surface proteins
JPS56150020A (en) Proliferation of b type hepatitis surface antigen
DE3275998D1 (en) Immunological composition and method for hepatitis b virus
EP0503950A3 (en) Method of purifying recombinant hepatitis b virus surface proteins from recombinant cells
GB2066454B (en) Sorting of particles
EP0542753A4 (en) Epitopes of the pre-s region of hepatitis b virus surface antigen
FI822018A0 (fi) Foerfarande foer framstaellning av ren hepatitis b ytantigen ur maenniskans plasma
GB2181434A (en) Hepatitis b virus vaccine and process for its preparation
FR2486802B1 (fr) Purification de l'antigene de surface de l'hepatite b (hbsag)
PT79064A (en) Process for preparing veccines and compositions against hepatitis b viral infections
GB8622883D0 (en) Expression of hepatitis b viral antigens